Olufunmilayo Olopade

Olopade in 2012 Olufunmilayo I. Olopade born in the year 1957, is a Nigerian hematology oncologist, Associate Dean for Global Health and Walter L. Palmer, Distinguished Service Professor in Medicine and Human Genetics at the University of Chicago. She also serves as director of the University of Chicago Hospital's Cancer Risk Clinic. Provided by Wikipedia
Showing 1 - 20 results of 53 for search 'Olufunmilayo I. Olopade', query time: 0.05s Refine Results
  1. 1
    Global disparities in breast cancer outcomes: new perspectives, widening inequities, unanswered questions

    Global disparities in breast cancer outcomes: new perspectives, widening inequities, unanswered questions by Mojisola Oluwasanu, Olufunmilayo I Olopade

    Published 2020-08-01
    Get full text
    Article
  2. 2
    Reply to Q. Chu et al

    Reply to Q. Chu et al by Jason T. Semprini, Olufunmilayo I. Olopade

    Published 2021-12-01
    Get full text
    Article
  3. 3
    Black Lives Matter Worldwide: Retooling Precision Oncology for True Equity of Cancer Care

    Black Lives Matter Worldwide: Retooling Precision Oncology for True Equity of Cancer Care by Padma Sheila Rajagopal, Olufunmilayo I. Olopade

    Published 2020-08-01
    Get full text
    Article
  4. 4
    Building local capacity for genomics research in Africa: recommendations from analysis of publications in Sub-Saharan Africa from 2004 to 2013

    Building local capacity for genomics research in Africa: recommendations from analysis of publications in Sub-Saharan Africa from 2004 to 2013 by Babatunde O. Adedokun, Christopher O. Olopade, Olufunmilayo I. Olopade

    Published 2016-05-01
    Get full text
    Article
  5. 5
    Pilot Survey of Breast Cancer Management in Sub-Saharan Africa

    Pilot Survey of Breast Cancer Management in Sub-Saharan Africa by Verna D.N.K. Vanderpuye, Olufunmilayo I. Olopade, Dezheng Huo

    Published 2017-06-01
    Get full text
    Article
  6. 6
    The optimization of postoperative radiotherapy in de novo stage IV breast cancer: evidence from real-world data to personalize treatment decisions

    The optimization of postoperative radiotherapy in de novo stage IV breast cancer: evidence from real-world data to personalize treatment decisions by Minoru Miyashita, Onyinye B. Balogun, Olufunmilayo I. Olopade, Dezheng Huo

    Published 2023-02-01
    Get full text
    Article
  7. 7
    Genetic and Epigenetic Regulation of TOX3 Expression in Breast Cancer.

    Genetic and Epigenetic Regulation of TOX3 Expression in Breast Cancer. by Yoo-Jeong Han, Jing Zhang, Yonglan Zheng, Dezheng Huo, Olufunmilayo I Olopade

    Published 2016-01-01
    Get full text
    Article
  8. 8
    Traditional medicine usage among adult women in Ibadan, Nigeria: a cross-sectional study

    Traditional medicine usage among adult women in Ibadan, Nigeria: a cross-sectional study by Suellen Li, Stella Odedina, Imaria Agwai, Oladosu Ojengbede, Dezheng Huo, Olufunmilayo I. Olopade

    Published 2020-03-01
    Get full text
    Article
  9. 9
    Trans-ethnic predicted expression genome-wide association analysis identifies a gene for estrogen receptor-negative breast cancer.

    Trans-ethnic predicted expression genome-wide association analysis identifies a gene for estrogen receptor-negative breast cancer. by Guimin Gao, Brandon L Pierce, Olufunmilayo I Olopade, Hae Kyung Im, Dezheng Huo

    Published 2017-09-01
    Get full text
    Article
  10. 10
    β-Catenin is required for the tumorigenic behavior of triple-negative breast cancer cells.

    β-Catenin is required for the tumorigenic behavior of triple-negative breast cancer cells. by Jinhua Xu, Jenifer R Prosperi, Noura Choudhury, Olufunmilayo I Olopade, Kathleen H Goss

    Published 2015-01-01
    Get full text
    Article
  11. 11
    Microsatellites in the estrogen receptor (ESR1, ESR2) and androgen receptor (AR) genes and breast cancer risk in African American and Nigerian women.

    Microsatellites in the estrogen receptor (ESR1, ESR2) and androgen receptor (AR) genes and breast cancer risk in African American and Nigerian women. by Yonglan Zheng, Dezheng Huo, Jing Zhang, Toshio F Yoshimatsu, Qun Niu, Olufunmilayo I Olopade

    Published 2012-01-01
    Get full text
    Article
  12. 12
    Impact of post-diagnosis weight change on survival outcomes in Black and White breast cancer patients

    Impact of post-diagnosis weight change on survival outcomes in Black and White breast cancer patients by Lihua Shang, Masaya Hattori, Gini Fleming, Nora Jaskowiak, Donald Hedeker, Olufunmilayo I. Olopade, Dezheng Huo

    Published 2021-02-01
    Get full text
    Article
  13. 13
    Infrastructural Challenges Lead to Delay of Curative Radiotherapy in Nigeria

    Infrastructural Challenges Lead to Delay of Curative Radiotherapy in Nigeria by Jim Leng, Atara I. Ntekim, Abiola Ibraheem, Chidinma P. Anakwenze, Daniel W. Golden, Olufunmilayo I. Olopade

    Published 2020-11-01
    Get full text
    Article
  14. 14
    Molecular Subtype-Specific Expression of MicroRNA-29c in Breast Cancer Is Associated with CpG Dinucleotide Methylation of the Promoter.

    Molecular Subtype-Specific Expression of MicroRNA-29c in Breast Cancer Is Associated with CpG Dinucleotide Methylation of the Promoter. by Elizabeth Poli, Jing Zhang, Chika Nwachukwu, Yonglan Zheng, Babatunde Adedokun, Olufunmilayo I Olopade, Yoo-Jeong Han

    Published 2015-01-01
    Get full text
    Article
  15. 15
    HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways

    HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways by Yuanyuan Yan, Fangxiao Liu, Li Han, Lin Zhao, Jianjun Chen, Olufunmilayo I Olopade, Miao He, Minjie Wei

    Published 2018-10-01
    Get full text
    Article
  16. 16
    Subtype-specific expression of MELK is partly due to copy number alterations in breast cancer.

    Subtype-specific expression of MELK is partly due to copy number alterations in breast cancer. by Ashley A Hardeman, Yoo Jane Han, Tatyana A Grushko, Jeffrey Mueller, Maria J Gomez, Yonglan Zheng, Olufunmilayo I Olopade

    Published 2022-01-01
    Get full text
    Article
  17. 17
    Factors associated with breast disorders detected by clinical breast examination during pregnancy and six months postpartum in Ibadan, South-western Nigeria

    Factors associated with breast disorders detected by clinical breast examination during pregnancy and six months postpartum in Ibadan, South-western Nigeria by Stella O. Odedina, IkeOluwapo O. Ajayi, Imran O. Morhason-Bello, Babatunde Adedokun, Dezheng Huo, Olufunmilayo I. Olopade, Oladosu A. Ojengbede

    Published 2022-10-01
    Get full text
    Article
  18. 18
    A metabolome-wide case-control study of african american breast cancer patients

    A metabolome-wide case-control study of african american breast cancer patients by Jiajun Luo, Muhammad G. Kibriya, Hui Chen, Karen Kim, Habibul Ahsan, Olufunmilayo I. Olopade, Christopher S. Olopade, Briseis Aschebrook-Kilfoy, Dezheng Huo

    Published 2023-02-01
    Get full text
    Article
  19. 19
    Regulation of Tcf7l1 DNA Binding and Protein Stability as Principal Mechanisms of Wnt/β-Catenin Signaling

    Regulation of Tcf7l1 DNA Binding and Protein Stability as Principal Mechanisms of Wnt/β-Catenin Signaling by Brian R. Shy, Chun-I. Wu, Galina F. Khramtsova, Jenny Y. Zhang, Olufunmilayo I. Olopade, Kathleen H. Goss, Bradley J. Merrill

    Published 2013-07-01
    Get full text
    Article
  20. 20
    A longitudinal study of the prevalence and characteristics of breast disorders detected by clinical breast examination during pregnancy and six months postpartum in Ibadan, Southwestern Nigeria

    A longitudinal study of the prevalence and characteristics of breast disorders detected by clinical breast examination during pregnancy and six months postpartum in Ibadan, Southwe... by Stella O. Odedina, IkeOluwapo O. Ajayi, Adenike Adeniji-Sofoluwe, Imran O. Morhason-Bello, Dezheng Huo, Olufunmilayo I. Olopade, Oladosu A. Ojengbede

    Published 2018-09-01
    Get full text
    Article

Search Tools: